Articles by Bob Sharma SA

  • Posted on 9/11/18

    Clearside Biomedical: Buy Or Sell Before 2018 Catalysts

    SummaryThe 8-week data from the first phase 3 trial (SAPPHIRE) in treating macular edema due to retinal vein occlusion is expected in Q4 (a big binary . . .

  • Posted on 8/27/18

    Agenus: Buy Or Sell?

    SummaryBull and bear cases for Agenus (AGEN), immune-oncology company are discussed on the request of a marketplace service subscriber.The company has a diverse pipeline in immune-oncology, . . .